Thermo Fisher Scientific Inc (TMO)
517.18
+4.34
(+0.85%)
USD |
NYSE |
Nov 21, 16:00
516.08
-1.10
(-0.21%)
After-Hours: 18:17
Thermo Fisher Scientific Debt to Equity Ratio: 0.7208 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.7208 |
June 30, 2024 | 0.7464 |
March 31, 2024 | 0.7823 |
December 31, 2023 | 0.7471 |
September 30, 2023 | 0.7784 |
June 30, 2023 | 0.7773 |
March 31, 2023 | 0.8343 |
December 31, 2022 | 0.7842 |
September 30, 2022 | 0.6696 |
June 30, 2022 | 0.7155 |
March 31, 2022 | 0.812 |
December 31, 2021 | 0.8548 |
September 30, 2021 | 0.5608 |
June 30, 2021 | 0.5095 |
March 31, 2021 | 0.5318 |
December 31, 2020 | 0.6299 |
September 30, 2020 | 0.6628 |
June 30, 2020 | 0.7134 |
March 31, 2020 | 0.6992 |
December 31, 2019 | 0.5982 |
September 30, 2019 | 0.5809 |
June 30, 2019 | 0.6627 |
March 31, 2019 | 0.6553 |
December 31, 2018 | 0.6884 |
September 30, 2018 | 0.6982 |
Date | Value |
---|---|
June 30, 2018 | 0.7344 |
March 31, 2018 | 0.8014 |
December 31, 2017 | 0.8267 |
September 30, 2017 | 0.8903 |
June 30, 2017 | 0.7501 |
March 31, 2017 | 0.7832 |
December 31, 2016 | 0.7719 |
September 30, 2016 | 0.8732 |
June 30, 2016 | 0.6653 |
March 31, 2016 | 0.7186 |
December 31, 2015 | 0.5842 |
September 30, 2015 | 0.6385 |
June 30, 2015 | 0.6781 |
March 31, 2015 | 0.746 |
December 31, 2014 | 0.7088 |
September 30, 2014 | 0.7058 |
June 30, 2014 | 0.754 |
March 31, 2014 | 0.8498 |
December 31, 2013 | 0.6222 |
September 30, 2013 | 0.4326 |
June 30, 2013 | 0.4502 |
March 31, 2013 | 0.4563 |
December 31, 2012 | 0.4607 |
September 30, 2012 | 0.4887 |
June 30, 2012 | 0.4327 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.5095
Minimum
Jun 2021
0.8548
Maximum
Dec 2021
0.7064
Average
0.7182
Median
Debt to Equity Ratio Benchmarks
Fonar Corp | 0.0005 |
XWELL Inc | 0.00 |
ProPhase Labs Inc | 0.4506 |
Applied DNA Sciences Inc | 0.00 |
Veracyte Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 100.36B |
Total Liabilities (Quarterly) | 51.26B |
Shareholders Equity (Quarterly) | 48.99B |
Current Ratio | 1.629 |
Net Debt Paydown Yield | -0.11% |